Evolution of antibody humanization and affinity maturation

Written by Sino Biological
Cancer research Drug discovery and development Immunology

Antibody humanization and affinity maturation have revolutionized the biotech industry in the past 10–20 years, enabling the development of highly effective therapeutic antibodies that can be used to treat a wide range of diseases.

In this Application Note, experts from Sino Biological provide an overview of the evolution of antibody humanization and affinity maturation processes, as well as the role AI plays in these processes.

To BioTechniques-Evolution of Antibody Humanization and Affinity Maturation (1)

This content was provided by

Follow Sino Biological on Twitter, Facebook and on LinkedIn.

 

Submit Your Research to the F1000Research Oncology Gateway

Share your oncology research with the global scientific community through the F1000Research Oncology Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of research integrity while driving innovation in cancer treatment and understanding.

Join a trusted platform that accelerates progress in oncology. Submit your research today at F1000Research Oncology Gateway.